Moshe Ornstein, MD on Phase 1B Trial of Neoadjuvant/adjuvant Durvalumab in RCC #ASCO2020 @MosheOrnsteinMD #ASCO @ClevelandClinic

Moshe Ornstein, MD on Phase 1B Trial of Neoadjuvant/adjuvant Durvalumab in RCC #ASCO2020 @MosheOrnsteinMD #ASCO @ClevelandClinic

User Photo
Cancer-News

6 months
70 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Moshe Ornstein, MD @MosheOrnsteinMD of Cleveland Clinic @ClevelandClinic discusses a phase Ib trial of neoadjuvant/adjuvant durvalumab +/- tremelimumab in locally advanced renal cell carcinoma (RCC) at this year's virtual ASCO 2020.
Up Next Autoplay
>